| Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ SA Kliewer, SS Sundseth, SA Jones, PJ Brown, GB Wisely, CS Koble, ... Proceedings of the National Academy of Sciences 94 (9), 4318-4323, 1997 | 2800 | 1997 |
| The PPARs: from orphan receptors to drug discovery TM Willson, PJ Brown, DD Sternbach, BR Henke Journal of medicinal chemistry 43 (4), 527-550, 2000 | 2488 | 2000 |
| Molecular recognition of fatty acids by peroxisome proliferator–activated receptors HE Xu, MH Lambert, VG Montana, DJ Parks, SG Blanchard, PJ Brown, ... Molecular cell 3 (3), 397-403, 1999 | 1528 | 1999 |
| The promise and peril of chemical probes CH Arrowsmith, JE Audia, C Austin, J Baell, J Bennett, J Blagg, C Bountra, ... Nature chemical biology 11 (8), 536-541, 2015 | 880 | 2015 |
| A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells M Vedadi, D Barsyte-Lovejoy, F Liu, S Rival-Gervier, A Allali-Hassani, ... Nature chemical biology 7 (8), 566-574, 2011 | 578 | 2011 |
| An orally bioavailable chemical probe of the lysine methyltransferases EZH2 and EZH1 KD Konze, A Ma, F Li, D Barsyte-Lovejoy, T Parton, CJ MacNevin, F Liu, ... ACS chemical biology 8 (6), 1324-1334, 2013 | 501 | 2013 |
| Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia F Grebien, M Vedadi, M Getlik, R Giambruno, A Grover, R Avellino, ... Nature chemical biology 11 (8), 571-578, 2015 | 305 | 2015 |
| Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors W Yu, EJ Chory, AK Wernimont, W Tempel, A Scopton, A Federation, ... Nature communications 3 (1), 1288, 2012 | 305 | 2012 |
| Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP F Liu, D Barsyte-Lovejoy, F Li, Y Xiong, V Korboukh, XP Huang, ... Journal of medicinal chemistry 56 (21), 8931-8942, 2013 | 287 | 2013 |
| Activation of peroxisome proliferator–activated receptor-α protects the heart from ischemia/reperfusion injury T Yue, W Bao, BM Jucker, J Gu, AM Romanic, PJ Brown, J Cui, ... Circulation 108 (19), 2393-2399, 2003 | 273 | 2003 |
| A potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases MS Eram, Y Shen, MM Szewczyk, H Wu, G Senisterra, F Li, KV Butler, ... ACS chemical biology 11 (3), 772-781, 2016 | 267 | 2016 |
| Discovery of a 2, 4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a F Liu, X Chen, A Allali-Hassani, AM Quinn, GA Wasney, A Dong, ... Journal of medicinal chemistry 52 (24), 7950-7953, 2009 | 258 | 2009 |
| Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2, 4-diamino-7-aminoalkoxy-quinazolines. F Liu, X Chen, A Allali-Hassani, AM Quinn, TJ Wigle, GA Wasney, A Dong, ... Journal of medicinal chemistry 53 (15), 5844-5857, 2010 | 231 | 2010 |
| Identification of a subtype selective human PPARα agonist through parallel-array synthesis PJ Brown, LW Stuart, KP Hurley, MC Lewis, DA Winegar, JG Wilson, ... Bioorganic & medicinal chemistry letters 11 (9), 1225-1227, 2001 | 220 | 2001 |
| Discovery and development of potent and selective inhibitors of histone methyltransferase g9a RF Sweis, M Pliushchev, PJ Brown, J Guo, F Li, D Maag, AM Petros, ... ACS medicinal chemistry letters 5 (2), 205-209, 2014 | 201 | 2014 |
| Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain LI James, D Barsyte-Lovejoy, N Zhong, L Krichevsky, VK Korboukh, ... Nature chemical biology 9 (3), 184-191, 2013 | 201 | 2013 |
| A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARα agonist with potent lipid-lowering activity PJ Brown, DA Winegar, KD Plunket, LB Moore, MC Lewis, JG Wilson, ... Journal of medicinal chemistry 42 (19), 3785-3788, 1999 | 201 | 1999 |
| (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells D Barsyte-Lovejoy, F Li, MJ Oudhoff, JH Tatlock, A Dong, H Zeng, H Wu, ... Proceedings of the National Academy of Sciences 111 (35), 12853-12858, 2014 | 193 | 2014 |
| Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5 G Senisterra, H Wu, A Allali-Hassani, GA Wasney, D Barsyte-Lovejoy, ... Biochemical Journal 449 (1), 151-159, 2013 | 178 | 2013 |
| Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines F Liu, D Barsyte-Lovejoy, A Allali-Hassani, Y He, JM Herold, X Chen, ... Journal of medicinal chemistry 54 (17), 6139-6150, 2011 | 172 | 2011 |
